A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma

NCT06683885 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Newly Diagnosed Diffuse Large B-cell Lymphoma

Interventions

DRUG: Obutinib or Decitabine, Rituximab, Compound Cyclophosphamide Tablets and Prednisone

Sponsor

Mingzhi Zhang